CSIMarket
 
Elutia Inc   (NASDAQ: ELUT)
Other Ticker:  
 
 
 

Elutia Inc 's vs. its Competitors Results

(List of Competitors, Financial Results 12 Months from the last period ending MRQ, in Millions of $)



 
COMPANY NAME TICKER REVENUE NET INCOME NET MARGIN CASH FLOW
Elutia Inc 1 Q 2025 ELUT 23.32 -39.89 - 4.81
Novavax inc 1 Q 2025 NVAX 1,254.96 478.70 38.14 % -217.46
Integra Lifesciences Holdings Corp 1 Q 2025 IART 1,624.31 -28.96 -1.78 % -352.80
Valneva Se 4 Q 2023 VALN 172.16 -113.60 -65.99 % 388.29
Organogenesis Holdings Inc 1 Q 2025 ORGO 458.76 -19.90 -4.34 % 21.19
Vaxart Inc 1 Q 2025 VXRT 47.40 -58.12 -122.63 % 1.96
Adaptimmune Therapeutics Plc 1 Q 2025 ADAP 181.45 -69.90 -38.52 % -100.52
Alector Inc 1 Q 2025 ALEC 88.34 -123.44 -139.74 % -34.28
Vir Biotechnology Inc 1 Q 2025 VIR 20.86 -577.65 -2769.04 % 187.52
Dyadic International Inc 1 Q 2025 DYAI 3.55 -5.83 -163.94 % -5.50
Mymetics Corporation 3 Q 2023 MYMX 1.23 -14.31 -1164.71 % -0.38
Mink Therapeutics Inc 1 Q 2025 INKT 0.00 -9.74 - -2.58
Immunovant Inc 1 Q 2025 IMVT 0.00 -413.84 - 78.61
APROX. MARKET 1 Q SUBTOTAL 3,876.34 -996.46 - -35.96



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com